TAILoR (TelmisArtan and InsuLin Resistance in Human Immunodeficiency Virus [HIV]): An Adaptive-design, Dose-ranging Phase IIb Randomized Trial of Telmisartan for the Reduction of Insulin Resistance in HIV-positive Individuals on Combination Antiretroviral Therapy

BACKGROUND: Combination antiretroviral therapy results in metabolic abnormalities which increase cardiovascular disease risk. We evaluated whether telmisartan reduces insulin resistance in human immunodeficiency virus (HIV)–positive individuals on antiretrovirals. METHODS: We conducted a multicenter...

全面介紹

Na minha lista:
書目詳細資料
發表在:Clin Infect Dis
Main Authors: Pushpakom, Sudeep, Kolamunnage-Dona, Ruwanthi, Taylor, Claire, Foster, Terry, Spowart, Cath, García-Fiñana, Marta, Kemp, Graham J, Jaki, Thomas, Khoo, Saye, Williamson, Paula, Pirmohamed, Munir
格式: Artigo
語言:Inglês
出版: Oxford University Press 2020
主題:
Articles and Commentaries
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC7201422/
https://ncbi.nlm.nih.gov/pubmed/31425580
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciz589
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍